Predicted to enable mRNA binding activity. Predicted to be involved in regulation of alternative mRNA splicing, via spliceosome. Predicted to be active in nucleus. Is expressed in several structures, including genitourinary system; gut; liver; lung; and spleen. Orthologous to human RAVER1 (ribonucleoprotein, PTB binding 1). [provided by Alliance of Genome Resources, Apr 2022]